Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
3.
J Cosmet Laser Ther ; 22(3): 128-129, 2020 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-32496930

RESUMO

Brachioplasty, in addition to several nonsurgical interventions (e.g. cryolipolysis, noninvasive radiofrequency, and intense-focused ultrasound) have been described as efficacious in the elimination of excess skin laxity from the upper arms. Recently, fractional CO2 ablation has gained attention for its ability to reduce rhytids and improve skin texture on the face, neck, and hands. In this article, we report the first successful case of fractional CO2 ablation for upper arm contouring.


Assuntos
Braço , Contorno Corporal , Lasers de Gás , Terapia Fototérmica , Face , Humanos , Lasers de Gás/uso terapêutico , Pescoço
4.
Pediatr Dermatol ; 37(1): 190-191, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31769049

RESUMO

A 15-year-old girl presented with leg wounds that were sustained after waxing and subsequent chemical depilation. History revealed prior usage of chemical depilatories without irritation. Given this finding, we suspect that waxing disrupted the epidermal barrier and, therefore, rendered the patient more susceptible to severe irritant contact dermatitis upon depilation. While there are reported cases of irritant contact dermatitis and chemical burns secondary to waxing or depilatory cream use in adults, a literature review found no reported cases of chemical burns in a pediatric patient or adult consequent to using these methods in tandem.


Assuntos
Queimaduras Químicas/etiologia , Dermatite Irritante/etiologia , Remoção de Cabelo/efeitos adversos , Adolescente , Feminino , Humanos , Perna (Membro) , Creme para a Pele/efeitos adversos
5.
J Lasers Med Sci ; 11(4): 395-404, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33425289

RESUMO

Introduction: Darier disease (DD) is a chronic disease with high morbidity and limited treatment options. Laser efficacy in the treatment of DD remains understudied. Methods: A literature search conducted between 07/21/2017 and 05/05/2018 identified all original cases of DD treated with laser therapy. Results: Outcomes from 24 patients were reviewed, 22 patients were identified in the literature and 2 cases are included from our institution. Five types of lasers were identified [CO2 laser, Er:YAG laser, pulse dye laser [PDL], diode laser, erbium-doped fiber laser], with CO2 (46%) and PDL (42%) being the most common. Seventy-nine percent of patients were treated with more than one procedure (average, 3 procedures). The estimated body surface treated with each session ranged from 5%-50%. The most common adverse events came from CO2 and Er:YAG lasers and included dyspigmentation, pain, and post-laser erythema and edema. The time to response (mode, 1 month) was only reported in half of the studies. Conclusion: Laser treatments appear to be a promising alternative to standardized therapies in DD.

7.
Pediatr Dermatol ; 35(3): e196-e197, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29574945

RESUMO

A 12-year-old Hispanic boy with chronic atopic dermatitis and cushingoid features presented to our institution. He was being treated with an unknown quantity of oral prednisolone 15 mg/5 mL, equivalent to 70 mg/m2 /d of oral prednisone, purchased over the counter in El Salvador. Systemic corticosteroids are not recommended for chronic therapy of atopic dermatitis because of their significant adverse effects. Foreign-sourced pharmaceuticals account for almost half of the drugs consumed in the United States, which means that, to protect our patients, medical providers must inquire about and report unsafe medications deemed legal outside the United States to the Food and Drug Administration.


Assuntos
Síndrome de Cushing/induzido quimicamente , Glucocorticoides/efeitos adversos , Prednisolona/efeitos adversos , Prednisona/efeitos adversos , Criança , Síndrome de Cushing/diagnóstico , Dermatite Atópica/tratamento farmacológico , Humanos , Masculino , Prednisolona/administração & dosagem , Prednisona/administração & dosagem
9.
Pediatrics ; 140(4)2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28864554

RESUMO

Isotretinoin is the most effective acne therapy available, but has the potential for a number of adverse side effects, including transaminitis. The iPLEDGE isotretinoin program recommends avoiding some herbals and supplements due to potential side effects. However, little is known about the effects of protein supplements on the liver, particularly in patients taking isotretinoin. We designed a retrospective chart review to evaluate the symptoms, diagnosis, treatment, and outcome of patients on or preparing to take isotretinoin therapy who were concurrently ingesting protein or herbal supplementation and who developed transaminitis. In 100% (8/8) of cases, dietary supplementation was determined to be at least a possible cause of elevated liver transaminases. In 75% (6/8) of cases, dietary supplement appears to be the most likely cause at some point in their evaluation. Most of our patients' elevations in aspartate aminotransferase and/or alanine aminotransferase were likely caused by supplementation with protein, creatine, or herbal extracts, rather than prescribed isotretinoin or tetracycline antibiotics for acne. Hence, dietary supplementation may cause liver function abnormalities. As supplement usage appears common in teenagers, clinicians should consider counseling their patients to avoid these products, particularly when prescribing known hepatotoxic drugs.


Assuntos
Acne Vulgar/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Fármacos Dermatológicos/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Isotretinoína/efeitos adversos , Adolescente , Biomarcadores/metabolismo , Camellia sinensis/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/enzimologia , Creatina/efeitos adversos , Fármacos Dermatológicos/uso terapêutico , Proteínas Alimentares/efeitos adversos , Feminino , Seguimentos , Humanos , Isotretinoína/uso terapêutico , Masculino , Preparações de Plantas/efeitos adversos , Estudos Retrospectivos , Transaminases/metabolismo , Resultado do Tratamento
11.
Arch Dis Child ; 102(9): 858-863, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28351834

RESUMO

Tuberous sclerosis complex (TSC) is a multisystem genetic disorder stemming from unregulated activation of the mammalian target of rapamycin (mTOR) pathway, resulting in the growth of hamartomas in multiple organs. TSC-related skin lesions often develop early in life and can be disfiguring, emotionally distressful and even painful at times. Recognition of TSC-associated skin features by paediatricians can be a catalyst for facilitating early implementation of treatment strategies and establishing appropriate follow-up care. The range of potential treatment options for symptomatic or disfiguring TSC-associated skin lesions includes non-pharmacological (surgical excision, laser therapy) and pharmacological (eg, topical or systemic mTOR inhibitors) alternatives. In this review, we discuss the relevance of TSC-associated skin findings, highlight available treatment options, review guideline recommendations and emphasise the role of the primary care physician in the management of this complex disease.


Assuntos
Pediatras , Papel do Médico , Dermatopatias/etiologia , Esclerose Tuberosa/complicações , Antibióticos Antineoplásicos/uso terapêutico , Humanos , Guias de Prática Clínica como Assunto , Sirolimo/uso terapêutico , Dermatopatias/diagnóstico , Dermatopatias/terapia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/terapia , Serina-Treonina Quinases TOR/antagonistas & inibidores , Esclerose Tuberosa/diagnóstico , Esclerose Tuberosa/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA